Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes and vascular disease.

A J Garber1

  • 1Vascular Disease Working Group, 6550 Fannin Street, Suite 1045, Houston, TX 77030, USA. llevine@bcm.tmc.edu

Diabetes, Obesity & Metabolism
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy.

Diabetes, obesity & metabolism·2014
Same author

What is the best approach to glycaemic control in patients with type 2 diabetes?

Diabetes, obesity & metabolism·2014
Same author

Will the next generation of basal insulins offer clinical advantages?

Diabetes, obesity & metabolism·2013
Same author

Treat-to-target trials: uses, interpretation and review of concepts.

Diabetes, obesity & metabolism·2013
Same author

Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents.

Diabetes, obesity & metabolism·2013
Same author

Methods to enhance delivery of prandial insulin and basal-prandial insulin.

Diabetes, obesity & metabolism·2013

Cardiovascular and cerebrovascular diseases significantly impact health globally, especially in diabetic patients. Strict blood sugar, blood pressure, and lipid management are crucial for reducing risks in this population.

Area of Science:

  • Cardiology
  • Neurology
  • Endocrinology

Background:

  • Cardiovascular and cerebrovascular diseases are leading causes of death globally.
  • Diabetes exacerbates the risk and impact of these vascular conditions.
  • Understanding these risks is vital for patient outcomes.

Purpose of the Study:

  • To review the impact of cardiovascular and cerebrovascular disease in the general population.
  • To specifically examine the impact in patients with diabetes.
  • To suggest appropriate treatment strategies for vascular disease in diabetics.

Main Methods:

  • Literature review on vascular disease prevalence and impact.
  • Analysis of risk factors in diabetic versus non-diabetic populations.
  • Synthesis of current treatment guidelines.

Related Experiment Videos

Main Results:

  • Vascular diseases pose a major health burden worldwide.
  • Diabetic patients face a substantially higher risk and severity of vascular events.
  • Effective management strategies are identified.

Conclusions:

  • Strict glycaemic control is essential for diabetic patients.
  • Hypertension control is a key factor in reducing vascular risk.
  • Lipid modification (dyslipidaemia management) is critical for prevention.